Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Parvatiyar, M., Pinto, J., Dweck, D., & Potter, J. (2010). Cardiac Troponin Mutations and Restrictive Cardiomyopathy. Journal Of Biomedicine & Biotechnology. Retrieved from http://dx.doi.org/10.1155/2010/350706
Mutations in sarcomeric proteins have recently been established as heritable causes of Restrictive Cardiomyopathy (RCM). RCM is clinically characterized as a defect in cardiac diastolic function, such as, impaired ventricular relaxation, reduced diastolic volume and increased end-diastolic pressure. To date, mutations have been identified in the cardiac genes for desmin, alpha-actin, troponin I and troponin T. Functional studies in skinned muscle fibers reconstituted with troponin mutants have established phenotypes consistent with the clinical findings which include an increase in myofilament Ca(2+) sensitivity and basal force. Moreover, when RCM mutants are incorporated into reconstituted myofilaments, the ability to inhibit the ATPase activity is reduced. A majority of the mutations cluster in specific regions of cardiac troponin and appear to be mutational "hot spots". This paper highlights the functional and clinical characteristics of RCM linked mutations within the troponin complex.
Parvatiyar, M., Pinto, J., Dweck, D., & Potter, J. (2010). Cardiac Troponin Mutations and Restrictive Cardiomyopathy. Journal Of Biomedicine & Biotechnology. Retrieved from http://dx.doi.org/10.1155/2010/350706